{"id":30299,"date":"2023-07-01T23:05:57","date_gmt":"2023-07-02T03:05:57","guid":{"rendered":"https:\/\/ifintechworld.com\/investing\/biolingus-cayman-files-for-ipo\/"},"modified":"2023-07-01T23:05:58","modified_gmt":"2023-07-02T03:05:58","slug":"biolingus-cayman-files-for-ipo","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=30299","title":{"rendered":"BioLingus (Cayman) Files for IPO"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"MW-BT-CO-20230630-709941\" role=\"document\">\n<p>By Stephen Nakrosis<\/p>\n<pre><\/pre>\n<p>BioLingus (Cayman) Ltd. filed for an initial public offering Friday with the U.S. Securities and Exchange Commission.<\/p>\n<p>The company said its subsidiaries are developing sublingual, or under the tongue, methods to deliver peptides and proteins, such as insulin. &#8220;Many of the more effective drugs to treat diabetes and obesity are &#8216;biologics&#8217;, the vast majority of which currently have to be injected,&#8221; the company said.<\/p>\n<div class=\"paywall\">\n<p>BioLingus (Cayman) is a holding company whose main business operations are conducted through subsidiaries in Switzerland and, &#8220;to a lesser extent, HK SAR, the People&#8217;s Republic of China and Australia,&#8221; the company said<\/p>\n<p>The company also said it expects to offer 3 million ordinary shares priced between $15 a share and $16 a share.<\/p>\n<p>BioLingus (Cayman) said it intends to apply to list on the Nasdaq Capital Market under the symbol SUBL.<\/p>\n<p>Univest Securities is listed as the offering&#8217;s underwriter.<\/p>\n<pre><\/pre>\n<p>Write to Stephen Nakrosis at stephen.nakrosis@wsj.com<\/p>\n<pre><\/pre>\n<\/p><\/div>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.marketwatch.com\/story\/biolingus-cayman-files-for-ipo-a27fbf9d?mod=investing\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Stephen Nakrosis BioLingus (Cayman) Ltd. filed for an initial public offering Friday with the U.S. Securities and Exchange Commission. The company said its subsidiaries are developing sublingual, or under the tongue, methods to deliver peptides and proteins, such as insulin. &#8220;Many of the more effective drugs to treat diabetes and obesity are &#8216;biologics&#8217;, the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1898,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[239],"tags":[83],"class_list":["post-30299","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-investing","tag-featured","post_format-post-format-video"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BioLingus (Cayman) Files for IPO | iFintechWorld<\/title>\n<meta name=\"description\" content=\"By Stephen Nakrosis BioLingus (Cayman) Ltd. filed for an initial public offering Friday with the U.S. Securities and Exchange Commission. The company said\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=30299\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioLingus (Cayman) Files for IPO | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"By Stephen Nakrosis BioLingus (Cayman) Ltd. filed for an initial public offering Friday with the U.S. Securities and Exchange Commission. The company said\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=30299\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-02T03:05:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-02T03:05:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/mw_logo_social.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=30299#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=30299\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"BioLingus (Cayman) Files for IPO\",\"datePublished\":\"2023-07-02T03:05:57+00:00\",\"dateModified\":\"2023-07-02T03:05:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=30299\"},\"wordCount\":166,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=30299#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=30299\",\"url\":\"https:\/\/ifintechworld.com\/?p=30299\",\"name\":\"BioLingus (Cayman) Files for IPO | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-07-02T03:05:57+00:00\",\"dateModified\":\"2023-07-02T03:05:58+00:00\",\"description\":\"By Stephen Nakrosis BioLingus (Cayman) Ltd. filed for an initial public offering Friday with the U.S. Securities and Exchange Commission. The company said\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=30299#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=30299\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=30299#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioLingus (Cayman) Files for IPO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioLingus (Cayman) Files for IPO | iFintechWorld","description":"By Stephen Nakrosis BioLingus (Cayman) Ltd. filed for an initial public offering Friday with the U.S. Securities and Exchange Commission. The company said","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=30299","og_locale":"en_US","og_type":"article","og_title":"BioLingus (Cayman) Files for IPO | iFintechWorld","og_description":"By Stephen Nakrosis BioLingus (Cayman) Ltd. filed for an initial public offering Friday with the U.S. Securities and Exchange Commission. The company said","og_url":"https:\/\/ifintechworld.com\/?p=30299","og_site_name":"iFintechWorld","article_published_time":"2023-07-02T03:05:57+00:00","article_modified_time":"2023-07-02T03:05:58+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/mw_logo_social.png","type":"image\/png"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=30299#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=30299"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"BioLingus (Cayman) Files for IPO","datePublished":"2023-07-02T03:05:57+00:00","dateModified":"2023-07-02T03:05:58+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=30299"},"wordCount":166,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=30299#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=30299","url":"https:\/\/ifintechworld.com\/?p=30299","name":"BioLingus (Cayman) Files for IPO | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-07-02T03:05:57+00:00","dateModified":"2023-07-02T03:05:58+00:00","description":"By Stephen Nakrosis BioLingus (Cayman) Ltd. filed for an initial public offering Friday with the U.S. Securities and Exchange Commission. The company said","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=30299#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=30299"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=30299#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"BioLingus (Cayman) Files for IPO"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/30299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30299"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/30299\/revisions"}],"predecessor-version":[{"id":30300,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/30299\/revisions\/30300"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/1898"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}